Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
JPMorgan initiates SPX Technologies with an Overweight rating and a $260 target, signalling a favorable view on data-...
As rates stabilize in Q1 2026, loan officers are expanding beyond a single source to build a resilient pipeline by wo...
A bipartisan plan to extend a federal retirement-savings match to workers without employer plans surfaces, uniting a ...
Andreessen Horowitz’s crypto arm is raising its fifth fund, aiming about $2 billion with a close planned for mid-2026...
The Strait of Hormuz has seen traffic grind to a near standstill as conflict escalates, sending ripples through oil p...
Marvell Technology is poised to release earnings later this week, with investors focused on AI chip orders and optica...
Bitcoin breaches a key threshold as traders price in potential Fed rate cuts, sparking a broader crypto rally and ren...
Solana nears a critical price threshold near the mid-$90s, sparking renewed bets on a rebound. Derivatives flow point...
A viral deepfake video features aged versions of tech titans promoting a dystopian startup. It sparks debate over AI,...
Investors are watching a potential defense-spending surge as the iran conflict could feed new arms orders, lifting de...
The weekend U.S.–Iran strike left traditional markets offline, putting on-chain platforms at the center of price disc...